OR
XENT

Olympiad Research’s Intersect ENT, Inc XENT Stock Holding History

Olympiad Research’s Portfolio XENT Stock Details XENT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-125,990
Closed -$3.53M – 391
2022
Q1 		$3.53M Buy
125,990
+35,048
+39% +$960K 1.08% 24
2021
Q4 		$2.48M Hold
90,942
– – 0.9% 27
2021
Q3 		$2.47M Buy
+90,942
New +$2.25M 0.76% 56

Olympiad Research's XENT Position: Q2 2022 in Review

Olympiad Research sold out of Intersect ENT, Inc (XENT) in Q2 2022, closing a stake of 125,990 shares — an estimated $3.53M sold.

Olympiad Research first reported a position in XENT in Q3 2021 and held it in 3 quarters. The position peaked at $3.53M in Q1 2022. 0 funds tracked by Wall St. Rank hold XENT as of Q2 2022.

  • Olympiad Research reported no remaining Intersect ENT, Inc position as of Q2 2022 after selling out during the quarter.
  • Olympiad Research sold 125,990 Intersect ENT, Inc shares in Q2 2022, an estimated $3.53M.
  • Olympiad Research first reported a position in Intersect ENT, Inc in Q3 2021 and held it in 3 quarters.
  • Olympiad Research's Intersect ENT, Inc position peaked at $3.53M in Q1 2022.
  • 0 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q2 2022.

Based on Olympiad Research's 13F filing for Q2 2022, filed 8 Aug 2022.